Physician profile
Mohamed Teleb
NPI 1952589285
$5,766.83
in general payments reported to CMS, 2019-2025
22 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $182 · 2021: $463 · 2022: $179 · 2023: $2,918 · 2024: $778 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,409 · Food and Beverage: $2,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,409.05 |
| Food and Beverage | $2,321.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,269.78 | 2023 | Penumbra System |
| Abbott Laboratories | $704.44 | 2021-2025 | Cardiomems, Mitraclip |
| Medtronic, INC. | $450.48 | 2021-2025 | Solitaire X, Resolute Onyx |
| Microvention, INC. | $284.96 | 2024 | Web Aneurysm Embolization System |
| Abiomed | $246.52 | 2023-2025 | Impella |
| Imperative Care, INC | $213.77 | 2024 | Zoom 88-T Large Distal Platform |
| Inari Medical, INC. | $198.01 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $173.32 | 2019 | |
| Boston Scientific Corporation | $143.05 | 2021-2025 | Watchman Flx |
| Pfizer INC. | $139.26 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $137.17 | 2021 | |
| Cvrx, INC. | $136.50 | 2023 | Barostim Neo System |
| Amgen INC. | $121.84 | 2024 | Repatha |
| Heartflow, INC. | $111.90 | 2022 | |
| Philips North America LLC | $107.99 | 2025 | Lm Undivided |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $98.64 | 2025 | |
| Biosense Webster, INC. | $94.79 | 2024 | Carto 3 |
| Depuy Synthes Sales INC. | $52.37 | 2025 | Embotrap, Cerebase |
| Medtronic Vascular, INC. | $42.57 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.62 | 2020 | |
| Alnylam Pharmaceuticals INC. | $13.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Teleb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.